Advances in genetics related to the diagnosis and treatment of cancer have transformed the oncology specialty into one with more promising outcomes. Because of the Human Genome Project, the association between genetics and cancer is more clearly defined and healthcare professionals need to be...

Bortezomib-induced peripheral neuropathy (BIPN) often is difficult to manage or reverse once it occurs. Treatment usually involves dose-reduction, interruption, or cessation of therapy, as no other interventions have been proven effective. Oncology nurses must be vigilant and recognize BIPN early...

Novel therapies approved over the past decade for the management of multiple myeloma have contributed to improved overall survival in patients with newly diagnosed and relapsed disease. Nurses play a key role in educating, advocating for, and supporting patients throughout the continuum of care...